<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
"http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">

<!--
!!    MOE 2010.10 On-Line Manuals
!!    COPYRIGHT (C) 2010
!!        CHEMICAL COMPUTING GROUP INC.  ALL RIGHTS RESERVED.
!!-->

<!--	ph4.htm		Pharmacophore Editor and Search
!!
!!	01-sep-2009 (kg) new pictures, alt annotations, minor edits
!!	16-oct-2008 (kk) minor edits
!!	23-sep-2008 (jd) typos
!!	10-sep-2007 (ms) typos etc
!!	10-aug-2007 (pl) created
!!-->

<head>

<meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
<link rel="stylesheet" type="text/css"
href="../manstyle.css" />


<title>Pharmacophore Annotation Schemes</title>

<meta main_keywords atomm, centroid, projected, link />

<meta keywords query, bioisostere, metal ligator, donor, acceptor />
<meta keywords aromatic rings, ionic group />

</head>

<body bgcolor="#ffffff">
<a href="../index.htm"><img src="../images/logo.gif"
alt="CCG Logo" align="right" width="174" height="55" border="0" /></a>
<h4>MOE 2010.10</h4>
<h2>Pharmacophore Annotation Schemes</h2>
<hr noshade="noshade" />

<ul>
<li><a href="#Intro">Introduction</a></li>
<li><a href="#Annotations">Annotation Type Definitions</a></li>
    <ul>
    <li><a href="#AnnotHB">H-Bond Donors/Acceptors and Metal Ligators</a></li>
    <li><a href="#AnnotIon">Ionic Groups</a></li>
    <li><a href="#AnnotAro">Aromatic and &pi;-Rings</a></li>
    <li><a href="#AnnotHyd">Hydrophobes</a></li>
    <li><a href="#AnnotLink">Link (Scaffold Replacement)</a></li>
    </ul>
<li><a href="#Exposure">Solvent Exposure Filters</a></li>
<li><a href="#Custom">Custom Annotation Schemes</a></li>
<li><a href="#SeeAlso">See Also</a></li>
<li><a href="#Ref">References</a></li>
</ul>

<h2><a name="Intro"></a>Introduction</h2>
<p>
<img src="ph4_annot/annot.png" align="right" alt="Annotation Points" />
A <i>pharmacophore annotation scheme</i>, or more simply a <i>scheme</i>,
is an automatic procedure to assign pharmacophore <i>annotation points</i>
(such as H-bond donor, H-bond acceptor, hydrophobe, etc.) to a 3D
conformation of a molecule.
The pharmacophore annotation points
are not part of the molecule proper, even though some of the annotation points 
may be located directly on top of a particular atom of the molecule.
The annotation points are what are examined by the MOE pharmacophore search;
in other words, the annotation points are what the pharmacophore search
&quot;sees&quot; when considering a particular molecular conformation.
In contrast, a <i>pharmacophore query</i> is a collection of
<i>query features</i> forming a (possibly complex) pattern that may or
may not match a particular set of annotation points of a conformation.

MOE has a variety of built-in schemes which provide different types of
annotations and use different policies to locate the annotations about a
particular conformation.  Custom schemes can also be implemented in SVL.
</p>

<p>
Annotation points divide into three broad categories:
</p>

<ol>
<li><i>Atom annotations</i> are located directly on an atom of a molecule,
such as &quot;H-bond donor&quot; or &quot;cation&quot; and typically indicate
a function related to protein-ligand binding.
</li>

<li><i>Centroid Annotations</i> are located at the geometric center of
a subset of the atoms of a molecule.  For example, an aromatic ring
annotation will typically be located at the centroid of the atoms of
the ring.  Centroid annotations can also be used to indicate hydrophobic
regions.
</li>

<li><i>Projected Annotations</i> are (typically) located along implicit
lone pair directions or implicit hydrogen directions and are used to
annotate the location of possible hydrogen bond partners,
metal ligation partners, or possible R-group atom locations.
</li>
</ol>

<p>
In the remainder of this document, the particulars of the MOE pharmacophore
schemes will be described along with the methods used to determine the
locations of the annotations supported by each scheme.
</p>
<h2><a name="Annotations"></a>Annotation Type Definitions</h2>
<p>
The pharmacophore annotation schemes have
many annotation points in common; however, there are some differences related
to geometry calculations and the precise algorithmic and/or chemical
typing details.  Setting these details aside, the following table
shows the collection of annotation point types and their support in each
of the standard schemes in MOE (scheme names are shown in the headings
of columns 2,3,4,...).
</p>

<blockquote>
<table class="titlebar">

<tr>
<th width="20%">Annotation Type</th>
<th width="9%"><tt>Unified</tt></th>
<th width="9%"><tt>PCHD</tt></th>
<th width="9%"><tt>CHD</tt></th>
<th width="9%"><tt>PCH</tt></th>
<th width="9%"><tt>PCH_All</tt></th>
<th width="9%"><tt>PPCH</tt></th>
<th width="9%"><tt>PPCH_All</tt></th>
</tr><tr>
<td>H-bond Donor</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>H-bond Donor Projection</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>H-bond Acceptor</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>H-bond Acceptor Projection</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>&pi; <i>vs.</i> non-&pi; H-bond Donor/Acceptor</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>General &pi; <i>vs.</i> non-&pi; Distinctions</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>Metal Ligator</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>Metal Ligator Projection</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>Cation</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>Anion</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>NCN+ Bioisostere</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>COO- Bioisostere</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>Aromatic Centroid</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>Aromatic Centroid Normal</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>&pi;-Ring Centroid</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>&pi;-Ring Centroid Normal</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>Hydrophobe</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
</tr><tr>
<td>Hydrophobic Centroid</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>R-Group Link</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr><tr>
<td>R-Group Link Projection</td>
<td style="text-align: center; vertical-align: middle">&nbsp;Y</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
<td style="text-align: center; vertical-align: middle">&nbsp;</td>
</tr>
</table>
</blockquote>

<p>
The <tt>Unified</tt> is the most comprehensive and includes all of the
annotation types of the other schemes.  The other schemes are provided
largely for compatibility with MOE versions prior to 2007 which, for
reasons of efficiency, provided schemes with subsets of the total
annotation collection.  In the 2007 version of MOE, the pharmacophore
system achieves the required efficiency with the <tt>Unified</tt> scheme
despite its large collection of annotation types.
</p>

<p>
<b>Note!</b> While the <tt>Unified</tt> scheme contains the annotation
types of all of the other schemes, its typing rules and geometry assignments
differ from the other schemes which largely share the same rules.
Some feature types, such as <tt>AccP</tt>, have been replaced by other
feature types in the <tt>Unified</tt> scheme, but are still available
in other schemes.  We mark these feature types as <i>obsolete</i>.
</p>

<p>
<b>Warning!</b> The annotation schemes assume that the input conformations
represent exact (washed) structures; in other words, carboxylate is considered
different from carboxylic acid and no implicit tautomer transformations
are performed.  <i>Molecules are annotated as-presented</i>.
</p>

<a name="AnnotHB"></a>
<h3>H-Bond Donors/Acceptors and Metal Ligators</h3>

<p>
The hydrogen bonding and metal ligation annotations consist of the following:
</p>

<ol>
<li><b>Don</b> annotates an H-bond donor heavy atom.</li>
<li><b>Don2</b> annotates projected locations of potential H-bond acceptors.</li>
<li><b>Acc</b> annotates an H-bond acceptor heavy atom.</li>
<li><b>Acc2</b> annotates projected locations of potential H-bond donors.</li>
<li><b>ML</b> annotates a metal ligator heavy atom.</li>
<li><b>ML2</b> annotates projected locations of potential ligated metals.</li>
<li><b>DonP</b> annotates an <i>sp</i> or <i>sp</i><sup>2</sup> H-bond donor
heavy atom (obsolete).</li>
<li><b>DonS</b> annotates an <i>sp</i><sup>3</sup> H-bond donor heavy atom
(obsolete).</li>
<li><b>AccP</b> annotates an <i>sp</i> or <i>sp</i><sup>2</sup> H-bond
acceptor heavy atom (obsolete).</li>
<li><b>AccS</b> annotates an <i>sp</i><sup>3</sup> H-bond acceptor heavy atom
(obsolete).</li>
</ol>

<p>
A <b>Don</b> annotation is added to all oxygen and nitrogen atoms with at
least one (possibly implicit) hydrogen attached.  Projected <b>Don2</b>
annotations are added according to the hybridization and the heavy atom
coordination of the donor.  In the following table the <b>d</b> denotes
a <b>Don2</b> feature.
</p>

<blockquote>
<table cellpadding="3" border="0" align="center">
<tr>
<td align="center" valign="middle"><img src="ph4_annot/don_g1.jpg" alt="Donor2 1" /></td>
<td align="center" valign="middle"><img src="ph4_annot/don_g2.jpg" alt="Donor2 2" /></td>
<td align="center" valign="middle"><img src="ph4_annot/don_g3.jpg" alt="Donor2 3" /></td>
</tr><tr>
<td align="center">
Q = 1&deg; <i>sp</i><sup>3</sup>,
X &gt;1-coord,
Y &ne; H
</td>
<td align="center">
Q = 2&deg; <i>sp</i><sup>3</sup>
</td>
<td align="center">
Q = 3&deg; <i>sp</i><sup>3</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle"><img src="ph4_annot/don_g4.jpg" alt="Donor2 4" /></td>
<td align="center" valign="middle"><img src="ph4_annot/don_g5.jpg" alt="Donor2 5" /></td>
<td align="center" valign="middle"><img src="ph4_annot/don_g6.jpg" alt="Donor2 6" /></td>
</tr><tr>
<td align="center">
Q = 1&deg; <i>sp</i><sup>2</sup>
</td>
<td align="center">
Q = 1&deg; <i>sp</i><sup>2</sup>, X &ne; H
</td>
<td align="center">
Q = 2&deg; <i>sp</i><sup>2</sup>
</td>
</tr>
<tr>
<td align="center" valign="middle"><img src="ph4_annot/don_g7.jpg" alt="Donor2 7" /></td>
<td align="center" valign="middle"><img src="ph4_annot/don_g8.jpg" alt="Donor2 8" /></td>
<td align="center" valign="middle">&nbsp;</td>
</tr><tr>
<td align="center">&nbsp;
Q : 2&deg; <i>sp</i><sup>2</sup></td>
<td align="center"> Q = 1&deg; <i>sp</i></td>
<td align="center">&nbsp;</td>
</tr>
</table>
</blockquote>

<p>
Hydrogen bond <b>Acc2</b> projected annotations are added to those
heavy atoms that qualify as H-bond acceptors (see below) and are given
<b>Acc</b> annotations.

The <b>Acc2</b> projected annotations
are added in the same locations as those for the <b>Don2</b> projected
annotations and according to the same rules.  (That is, the donors
and the acceptors are projected using the same angles and the same distances.)
An atom that is both a <b>Don</b> and an <b>Acc</b> will be
annotated with &quot;Don2&amp;Acc2&quot; projected annotations.
</p>

<p>
Only {O,S,N} elements can be hydrogen bond acceptors provided that they
conform to the following rules:
</p>

<ol>
<li>
Sulfur atoms are not acceptors except that sulfur in S=C groups and anionic
sulfurs are acceptors and are given <b>Acc</b> annotations.
</li>

<li>
Nitrogen atoms are acceptors and given <b>Acc</b> annotations provided that
they are not buried.  A buried nitrogen is one of
{=N=, &minus;N#, &gt;N=, &gt;N<}
or a non-3-ring conjugated nitrogen of the form
{&gt;N&minus;&pi;, &gt;N&minus;[C+], &gt;N&minus;B, &gt;N&minus;S=O,
&gt;N&minus;P=O}.
</li>

<li>
Oxygen atoms are acceptors and are given <b>Acc</b> annotations provided that
they are not buried and provided that they are not in certain exception groups. 
A buried oxygen is one of {=O=, &minus;O#; &gt;O=, &gt;O&lt;} or a
non-3-ring conjugated oxygen of the form {&gt;O&minus;&pi;, &gt;O&minus;B,
&gt;O&minus;[C+]}.
Non-buried oxygen atoms are acceptors unless they are part of the
following exception groups:
</li>

</ol>
<table cellpadding="3" border="1" align="center">
<tr>
<td align="center" valign="middle">
<img src="ph4_annot/acc_g1.jpg" alt="Acceptor2 1" />
<img src="ph4_annot/acc_g2.jpg" alt="Acceptor2 2" />
<br />not Acc; X<sub><i>i</i></sub> = any
</td>
<td align="center" valign="middle">
<img src="ph4_annot/acc_g3.jpg" alt="Acceptor2 3" />
<img src="ph4_annot/acc_g4.jpg" alt="Acceptor2 4" />
<br />not Acc if any X<sub><i>i</i></sub> = het; Y &ne; H
</td>
</tr><tr>
<td align="center" valign="middle">
<img src="ph4_annot/acc_g5.jpg" alt="Acceptor2 5" />
<img src="ph4_annot/acc_g6.jpg" alt="Acceptor2 6" />
<br />not Acc if Y &ne; H, E = {C#N, N#C, &gt;[N,S,P]=O, Q+, CF<sub>3</sub>}
</td>
<td align="center" valign="middle">
<img src="ph4_annot/acc_g7.jpg" alt="Acceptor2 7" />
<img src="ph4_annot/acc_g8.jpg" alt="Acceptor2 8" />
<br />not Acc if both {Q1,Q2} are &pi;
<br />not Acc if both {X1,X2} = het
</td>
</tr>
</table>

<p>The metal ligand annotation <b>ML</b> is
added to the heavy atom of all deemed metal ligands.
Anionic atoms and H-bond acceptor atoms are always given <b>ML</b> annotations
as well as certain specific groups such as phosphines and mercaptans.
Projected annotations <b>ML2</b> are added in the same positions
and according to the same rules as the <b>Don2</b> projected annotations.
</p>
<p>
The <b>DonP</b> and <b>DonS</b> annotations are unique to the <tt>PPCH</tt> and
<tt>PPCH_All</tt> schemes and further distinguish &pi; from non-&pi;
donors (respectively).
The <b>AccP</b> and <b>AccS</b> annotations are unique to the <tt>PPCH</tt> and
<tt>PPCH_All</tt> schemes and further distinguish &pi; from non-&pi;
acceptors (respectively).
The <b>DonP</b>, <b>DonS</b>, <b>AccP</b> and <b>AccS</b> are retained
for compatibility.  The <tt>Unified</tt> scheme achieves these distinctions
with use of the <b>pi</b> annotation.  This annotation is used to indicate
that any of <b>Acc</b>, <b>Acc2</b>, <b>Don</b>, <b>Don2</b>, <b>ML</b>
or <b>ML2</b> belong to an atom in a
&pi; system.  Thus <b>DonP</b> is equivalent to &quot;Don&amp;pi&quot; and
<b>DonS</b> can be specified in a query with the expression
&quot;Don&amp;!pi&quot;.
</p>

<a name="AnnotIon"></a>
<h3>Ionic Groups</h3>

<p>
The following annotations are used for ionic atoms and groups:
</p>
<ol>
<li><b>Ani</b> annotations are used on anionic heavy atoms.</li>
<li><b>Cat</b> annotations are used on cationic heavy atoms.</li>
<li><b>O2</b> annotations are used for bioisosteres of &minus;CO<sub>2</sub>.</li>
<li><b>CN2</b> annotations are used for bioisosteres of &minus;CN<sub>2</sub>.</li>
</ol>

<p>
The <b>Ani</b> annotation is assigned to heavy atoms with an excess of negative
charge, including excess charge due to resonances (of certain groups).
An atom with a formal negative charge not adjacent to an atom with a formal
positive charge will be assigned an <b>Ani</b> annotation.
Both oxygen atoms of [O&minus;]&minus;C=C&minus;C=O are also marked with
<b>Ani</b>.

Up to three anionic resonances between
[N&minus;,S&minus;,O&minus;] and [=N,=S,=O] are taken
into account in anionic carboxylates, (acyl) sulfonamides, muscimol,
anionic imidazole, tetrazole etc, and

up to four anionic {O,S} resonances in hydroxamic and
nitrosohydroxylamine anions.
</p>

<p>
The <b>Cat</b> annotation is assigned to heavy atoms with an excess of positive
charge, including excess charge due to resonances (of certain groups).
Generally, speaking an atom with a formal positive charge not adjacent to
an atom with a formal negative charge will be assigned a <b>Cat</b> annotation.
Care is taken to sum the charges in charge-separated ylides.
NCN+ resonances are taken into account with both nitrogen atoms marked
with a <b>Cat</b> annotation; for example, amidinium, imidazolium,
4-amino pyridine and all 3 nitrogens in guanidinium.
</p>

<p>
The <b>O2</b> annotation centroid is placed between certain pairs of
1&minus;3 <b>Ani</b>
{S,O,N} atoms and is intended to denote an anionic &minus;CO2 bioisostere.
An <b>O2</b> centroid is placed between each pair of <b>Ani</b> oxygens, sulfurs
and anionic divalent nitrogens (in any combination).  Thus, carboxylate
is given one <b>O2</b> centroid while &minus;PO<sub>3</sub> is given three
<b>O2</b> centroids (one between each pair of terminal Ani annotations).
An exception is the tetrazole anion in which a single <b>O2</b> annotation is
placed at the centroid of the four nitrogen atoms in the aromatic ring.
</p>

<p>
The <b>CN2</b> annotation centroid is placed on the carbon atom of NCN+
resonance structures and is intended to denote a cationic
&minus;CN<sub>2</sub> bioisostere.  The carbon between the nitrogens in
amidinium, guanidinium, 2-amino pyridinium, etc. are marked with
<b>CN2</b> annotations.
</p>

<p>
The <b>pi</b> annotation applies to the <b>Ani</b> and <b>Cat</b> annotations;
that is, if the annotated chemical group is a &pi; group then the
pi annotation will be added to the <b>Ani</b> or <b>Cat</b> annotations.
For example, amidinium nitrogens are annotated with &quot;Cat&amp;pi&quot;.
</p>

<a name="AnnotAro"></a>
<h3>Aromatic and &pi;-Rings</h3>

<p>
The following annotations are used for aromatic and &pi;-system rings:
</p>
<ol>
<li><b>Aro</b> annotation centroids are used for aromatic and pseudo
aromatic rings;</li>
<li><b>PiR</b> annotation centroids are used for other &pi;-system rings;</li>
<li><b>PiN</b> annotation centroid projections are used along the
&pi;-system plane normal;</li>
<li><b>Aro2</b> annotation centroid normals are used do annotate the
direction of the normal to the &pi; system of Aro rings; (obsolete)</li>
<li><b>HydP</b> annotation centroids are used for planar hydrophobic
rings. (obsolete)</li>
</ol>

<p>
The <b>Aro</b> annotation centroid is placed at the centroid of each
aromatic ring (e.g. two centroids in naphthalene).  The definition of
aromaticity depends on the particular scheme:
</p>

<ul>
<li><tt>Unified</tt>
The definition of aromaticity is generous (a Daylight-style definition) in
which each ring is treated in isolation and a Hueckel 4n+2 rule is applied.
C=O carbons count 0 electrons, otherwise C=R count as 1; N=X nitrogens count
1 and &gt;N&minus; nitrogens and &minus;O&minus; oxygens count
2 electrons.  Thus, the following are treated as (pseudo) aromatic and are
given an <b>Aro</b> annotation centroid in the center of the ring:
<p align="center">
<img src="ph4_annot/aro_g1.jpg" alt="Aro 1" />
<img src="ph4_annot/aro_g2.jpg" alt="Aro 2" />
<img src="ph4_annot/aro_g3.jpg" alt="Aro 3" />
<img src="ph4_annot/aro_g4.jpg" alt="Aro 4" />
</p>
</li>
<li><tt>PCH</tt>, <tt>PCHD</tt>, <tt>PCH_All</tt>, <tt>CHD</tt>.
The definition of aromaticity is strict - exocyclic double bonds destroy
aromatic properties of the ring.  A Hueckel 4n+2 rule is applied and each
&pi; system is treated in a fully consistent manner (no isolated tests).
In the above examples, only the left-most two rings are considered aromatic
and given an <b>Aro</b> centroid annotation at center of the ring.
</li>
<li><tt>PPCH</tt>, <tt>PCHD_All</tt>.
There is no definition of aromaticity in these schemes.  The <b>HydP</b>
centroid is used instead indicating a planar hydrophobic ring.
</li>
</ul>

<p>
The <b>PiR</b> annotation centroid is placed at the center of each
non-aromatic (non-<b>Aro</b>) &pi;-system ring; that is, each ring in which
all atoms are <i>sp</i>2 hybridized.  Thus, the following ring systems are
given <b>PiR</b> annotations:
</p>

<p align="center">
<img src="ph4_annot/pir_g1.jpg" alt="PiR 1" />
<img src="ph4_annot/pir_g2.jpg" alt="PiR 2" />
<img src="ph4_annot/pir_g3.jpg" alt="PiR 3" />
</p>

<p>
General planar rings can be matched with a query expression of the
form <tt>Aro&nbsp;|&nbsp;PiR</tt> (in the <tt>Unified</tt> scheme).
In the <tt>PPCH</tt> and <tt>PPCHD_All</tt> schemes, a <b>HydP</b> annotation
centroid will be used instead of the <b>PiR</b> centroid.
In the other schemes, a <b>HydP</b> annotation (planar hydrophobic) centroid
will be placed at the center of a &pi; ring if the majority of the ring atoms
are considered hydrophobic.
</p>

<p>
The <b>PiN</b> annotation projection is used (in the <tt>Unified</tt> scheme)
to annotate the direction of each &pi;-system and aromatic ring.  Each such
ring will generate two projected features along the normal to the
&pi;-system ring, above and below the ring plane.  For example,
</p>

<p align="center">
<img src="ph4_annot/pin_g1.png" alt="PiN 1" />
</p>
<p>
is an <b>Aro</b> aromatic ring annotation with the two <b>PiN</b> features.
In the <tt>PCHD</tt> scheme the <b>Aro2</b> centroid normal feature is
used instead of the <b>PiN</b> annotation, but only for rings marked
with <b>Aro</b>.
</p>

<a name="AnnotHyd"></a>
<h3>Hydrophobes</h3>

<p>
The hydrophobic annotations of the various schemes differ markedly.  Names and
concepts are used on a per-scheme basis.  Consequently, we will describe
the hydrophobic treatments separately:
</p>

<ol>
<li><tt>Unified</tt> annotates hydrophobic atoms with <b>HydA</b>
and hydrophobic centroids with <b>Hyd</b>.
</li>
<li><tt>PPCH</tt> only uses <b>HydP</b> for planar hydrophobic
centroids and <b>HydS</b> for non-planar hydrophobic centroids (no atoms).
</li>
<li><tt>PPCH_All</tt> uses <b>HydP</b> for planar hydrophobic
atoms and <b>HydS</b> for non-planar hydrophobic atoms (no centroids).
</li>
<li><tt>PCH</tt>, <tt>PCHD</tt> and <tt>CHD</tt> use <b>HydA</b> for
all hydrophobic centroids (no atoms).
</li>
<li><tt>PCH_all</tt> uses <b>HydA</b> for all hydrophobic atoms (no centroids).
</li>
</ol>

<p>
All of the schemes decide on hydrophobic annotations using the molecular
graph topology alone - no 3D coordinates are used in the designation.  Thus,
hydrophobic groups are determined by graph theoretic algorithms.
</p>

<p>
The fundamental rules for deciding whether an atom is hydrophobic are encoded
in the SVL function <tt>ph4_aHydrophobe</tt>.  A summary of these rules is:
</p>

<ol>
<li>
Nitro nitrogen atoms (not in nitrate anions) are hydrophobic.
</li>
<li>
Divalent sulfur atoms with two heavy neighbors bonded only
to carbon or sulfur are hydrophobic.
</li>
<li>Halogens are hydrophobic.
</li>
<li>
Carbon atoms are hydrophobic except
a)&nbsp;aliphatic carbons &pi; bonded to non-carbon atoms; or
b)&nbsp;&pi; carbon atoms adjacent to univalent oxygen; or
c)&nbsp;aromatic carbon adjacent to aromatic oxygen in 5-rings; or
d)&nbsp;carbon atoms adjacent to two or more {N,O} atoms; or
e)&nbsp;anionic carbons in <tt>c1cccc1</tt>;
</li>
</ol>

<p>
The assignment of hydrophobic annotations proceeds by first applying the
preceding hydrophobic atom typing rules but leaving out fluorine atoms
on the grounds that they are small and should not affect annotation
placement.
</p>

<p>
The <tt>Unified</tt> scheme provides an atom-centered hydrophobic
annotation, <b>HydA</b> and a centroid hydrophobic feature <b>Hyd</b>.
The <b>HydA</b> annotation is used for hydrophobic atoms that are deemed
to have sufficiently high (potential) exposure to a potential receptor.  This
means that, for example, <i>sp</i>3 carbons with 4 heavy neighbors are not
marked (since they are buried) and aromatic carbons with two heavy neighbors
and two <i>ortho</i> substituents are not annotated.
The <b>Hyd</b> annotations are assigned by a procedure that groups connected
hydrophobic atoms and assigns centroids weighted by an estimate of the
likely exposed surface area of each hydrophobic atom; that is, the
<b>Hyd</b> centroid will be placed closer to more exposed hydrophobic
atoms in a hydrophobic group.
</p>

The following grouping algorithm is used:
<ol>
<li><b>Strip Fluorines</b>.
Remove all fluorines that are not bonded to {H,F} from further consideration.
Note that estimates of exposed surface area use a fluorine suppressed molecule.
</li> 

<li><b>Rings</b>.
Find all 5-, 6-, 7-, and 8-member rings that are not composed of smaller rings.
For each such ring, extract each contiguous

stretch of hydrophobic atoms with at least three atoms that have a
sufficiently high total exposed surface area,

and generate a surface area weighted centroid annotation.
Remove all annotated ring atoms from further consideration.
</li>

<li><b>Components</b>.
Find all connected components (single-linkage clusters) among the remaining
hydrophobes and remove from consideration those clusters with an
exposed surface area sum small deemed too small (less than a -CH2- group).
</li>

<li><b>Small Components</b>.
For the remaining hydrophobic components with three or fewer atoms, generate
an exposed surface area weighted centroid annotation.
</li>

<li><b>Large Components</b>.
Identify the center of the component graph and generate a weighted
centroid at the center including its neighbors.  Remove the annotated
atoms, splitting the component and apply the Small Components step and/or
the Large Components step (recursively) to group the hydrophobes.
</li>
</ol>

<p>
For the <tt>PCH_All</tt> scheme, all hydrophobic atoms are given a <b>Hyd</b>
annotation.
For the <tt>PPCH_All</tt> scheme, all hydrophobic atoms are given a
<b>HydP</b> annotation if they are planar or in a &pi; system and <b>HydS</b>
otherwise. In either of the preceding two schemes, no centroids are used.

The <tt>PCH</tt>, <tt>PCHD</tt>, <tt>CHD</tt> and <tt>PPCH</tt> schemes use
only hydrophobic centroids to annotate hydrophobic regions.  Some of the
centroids may involve a single atom (e.g. a terminal methyl group); however,
such cases result from the output of partitioning/clustering algorithm used to
determine the hydrophobic centroids, all of which are marked with <b>Hyd</b>
annotations (<b>HydS</b> or <b>HydP</b> in the case of <tt>PPCH</tt>).
</p>

The following grouping algorithm is used:

<ol>
<li><b>Strip Fluorines</b>.
Remove all fluorines that are not bonded to {H,F} from further consideration.
</li>

<li><b>Rings</b>.
Find all 3-, 4-, 5-, 6-, 7-, and 8-member rings
that are not composed of smaller rings and contain at least 60% hydrophobes.
Generate an annotation point at the center of each such ring and remove
the annotated ring atoms from further consideration. 
</li>

<li><b>Terminals</b>.
Mark all remaining input atoms bonded to at least two other remaining input
atoms. Generate an annotation point for each terminal input atom that is
bonded to a marked atom and remove the terminal atom from further
consideration. 
</li>

<li><b>Components</b>.
Find all connected components (single-linkage clusters) among the remaining
input atoms and generate an annotation point at the centroid of each component. 
</li>
</ol>

<p>
The <tt>PPCH</tt> uses a modified version of the above partition method
which will assign <b>HydP</b> for planar groups and <b>HydS</b> for
non-planar groups.
</p>

<h3><a name="AnnotLink"></a>Link (Scaffold Replacement)</h3>

<p>
<img src="ph4_annot/link_Ri.png" align="right" alt="Link R1" />
Special Link pharmacophore query features are used for scaffold replacement.
</p>
<p>
It is possible to use the Link and projected Link features manually via the 
Pharmacophore Query Editor to design a scaffold replacement query, however a 
new <a href="scaffold.htm">Scaffold Replacement</a>
application was integrated in the 2009 version of MOE that was  designed to 
simplify the process of defining the scaffold and R-groups and 
generating the new optimised molecules. The Link scheme is used internally 
by the new Scaffold Replacement application. 
</p>
<p>
Link annotations denote points of substitution on a candidate scaffold molecule 
as well as the locations of potential R-group substituents.
</p>
<p>
There are three types of link annotation:
</p>
<ol>
<li><b>Link</b>
annotates a heavy atom substitution point with at least one (implicit) hydrogen.
</li>

<li><b>Link2</b>
annotates projected locations of potential <i>sp</i><sup>2</sup> R-groups.
</li>

<li><b>Link3</b>
annotates projected locations of potential <i>sp</i><sup>3</sup> R-groups.
</li>
</ol>

<p>
Both the heavy atom substitution point and the possible R-group location(s)
are given annotation points. The idea is to provide functionality similar
to Bartlett's CAVEAT methodology [Lauri&nbsp;1994].
A typical scaffold annotation appears as depicted here.
The yellow annotation spheres on the heavy atoms represent substitution
points and the annotations projected from the heavy atoms denote the locations
of potential R-group heavy atoms.
</p>

<p>
A typical query will consist of (<b>Link</b>,<b>Link2</b>)
or (<b>Link</b>,<b>Link3</b>) pairs located at positions intended to
represent scaffold / R-group bonds, as illustrated in the example below.
The <b>Link2</b> or <b>Link3</b> feature is placed on an existing
R-group heavy atom and the <b>Link</b> feature is intended to match
a heavy atom of a new scaffold to be found in a database of scaffold or
linker molecules.  A matching scaffold is more likely to present the
existing R-group in the proper direction.
</p>

<p><b>Note:</b> The middle image below is for purposes of
illustration only.  It is not necessary to delete the original
scaffold when using link annotations.
</p>

<p align="center">
<img src="ph4_annot/link_query.png" alt="Link Query" />
</p>

<p>
<b>Link3</b> query features are used when the R-group atom is
<i>sp</i><sup>3</sup>.  <b>Link2</b> query features are used when the
R-group atom is <i>sp</i><sup>2</sup>.  For example, when attempting to
match a piperazine scaffold with an aromatic R-group, a <b>Link2</b> query
feature should be used so that the piperazine nitrogen conjugated planar
geometry is used (and not the nitrogen tetrahedral geometry).
</p>

<p>
We now describe the annotations used to annotate scaffolds.
Only {C,N,O,S,P} atoms with 1, 2 or 3 heavy neighbors and at least one
(possibly implicit) hydrogen are candidates for <b>Link</b> features;
other atoms are not considered as candidates.
The following rules assume that the foregoing conditions are satisfied.
Not all such atoms will be given <b>Link</b> annotations: substituents on
freely rotatable single bonds will be avoided
(e.g. <i>sp</i><sup>2</sup>-<i>sp</i><sup>3</sup> rotors).
</p>

<blockquote>
<table cellpadding="3" border="0" align="center">
<tr>
<td align="center" valign="middle"><img src="ph4_annot/link_g1.jpg" alt="Link 1" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g2.jpg" alt="Link 2" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g3.jpg" alt="Link 3" /></td>
</tr><tr>
<td align="center">Q = any 1&deg;, X<sub><i>i</i></sub> = any</td>
<td align="center">Q = 1&deg; {C,N+}, Y = 2&deg; {O,S,N-}</td>
<td align="center">
N = 2&deg; or 3&deg;, Q<sub>1</sub> = 4-coord, Q<sub>2</sub> = any
</td>
</tr>
<tr>
<td align="center" valign="middle"><img src="ph4_annot/link_g4.jpg" alt="Link 4" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g16.jpg" alt="Link 5" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g6.jpg" alt="Link 6" /></td>
</tr><tr>
<td align="center">Y &ne; 1&deg; Q = {OH, SH, NH<sub>2</sub>, PH<sub>2</sub>}</td>
<td align="center">&nbsp;</td>
<td align="center">
Q = {C,N,P,S}, Q = 3&deg; <i>sp</i><sup>3</sup>,
R<sub><i>i</i></sub> &ne; H
</td>
</tr>

<tr>
<td align="center" valign="middle"><img src="ph4_annot/link_g7.jpg" alt="Link 7" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g8.jpg" alt="Link 8" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g9.jpg" alt="Link 9" /></td>
</tr><tr>
<td align="center">Q = 2&deg; aromatic</td>
<td align="center">Q = 2&deg; <i>sp</i><sup>2</sup></td>
<td align="center">Q = 1&deg; <i>sp</i><sup>2</sup></td>
</tr>
<tr>
<td align="center" valign="middle"><img src="ph4_annot/link_g10.jpg" alt="Link 10" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g11.jpg" alt="Link 11" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g12.jpg" alt="Link 12" /></td>
</tr><tr>
<td align="center">N = 2&deg; amide not in 3,4-ring</td>
<td align="center">N = 1&deg; amide not in 3,4-ring</td>
<td align="center">N = 2&deg; in NCN+ not in 3,4-ring</td>
</tr>
<tr>
<td align="center" valign="middle"><img src="ph4_annot/link_g13.jpg" alt="Link 13" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g14.jpg" alt="Link 14" /></td>
<td align="center" valign="middle"><img src="ph4_annot/link_g15.jpg" alt="Link 15" /></td>
</tr>
<tr>
<td align="center">N = 1&deg; in NCN+ not in 3,4-ring</td>
<td align="center">O = 1&deg;</td>
<td align="center">OH on Caro, X<sub><i>i</i></sub> = 2&deg;</td>
</tr>
<tr>
<td align="center" valign="middle">&nbsp;</td>
<td align="center" valign="middle"><img src="ph4_annot/link_g5.jpg" alt="Link 5" /></td>
<td align="center" valign="middle">&nbsp;</td>
</tr><tr>
<td align="center">&nbsp;</td>
<td align="center">
Q = 2&deg; {C,N} <i>sp</i><sup>3</sup>, X<sub><i>i</i></sub> &ne; H
</td>
<td align="center">&nbsp;</td>
</tr>
</table>
</blockquote>

<p>
Note that in most cases, <b>Link2</b> and <b>Link3</b> annotations are
used for the projected annotations.  For 2&deg; nitrogen and carbon atoms,
there is a distinction between <b>Link2</b> and <b>Link3</b> - <b>Link2</b>
projections are in the potential &pi; system plane and <b>Link3</b>
projections are in tetrahedral formation.
Also, note that <i>cis</i> peptide formation is avoided.
</p>

<h2><a name="Exposure"></a>Solvent Exposure Filters</h2>

<p> Projected annotations such as <b>Don2</b>, <b>Acc2</b>, <b>ML2</b>,
<b>Link2</b> and <b>Link3</b> are located at potential heavy atom
positions.  For example, <b>Don2</b> indicates a potential hydrogen bond
partner heavy atoms.  Realistically, this partner atom cannot have too
much overlap with any of the atoms of the molecule generating the
projected annotation.  This condition depends on the particular
conformation of a molecule and cannot be reliably predicted by
topological means.  Consequently, a <i>solvent exposure test</i> must be
applied to validate any hits resulting from the Pharmacophore Search.
</p>

<p>
If a conformation hits a query, the Pharmacophore Search will apply
a scheme-dependent test to verify that applicable projected features
are not covered by other parts of the conformation (that would prevent
the putative projection atom from occupying the intended position).
The nature of the test depends on the particular scheme, but in general,
it will ensure that no projected feature lies inside the hit conformation.
For example, the <tt>PCH</tt> does not use projected features, so no
test is applied whereas the <tt>PCHD</tt> does use projected features, but
the exposure rules are different for Aro2 and Don2 projections.
</p>

<p> <b>Note:</b> The Pharmacophore Query Editor displays all projected
annotation points, regardless their solvent exposure.  However, it does
indicate the solvent exposure status of the displayed annotation points
by their rendering mode: the annotation features that pass the solvent
exposure test (and that will be considered by the Pharmacophore Search)
are rendered as <i>small-sphere</i>.  The annotation features that do
not pass the test (and that will be ignored by the Pharmacophore Search)
are rendered as <i>point</i>.
</p>

<h2><a name="Custom"></a>Custom Annotation Schemes</h2>

<p>
Each of pharmacophore annotation schemes is an SVL function that accepts
a collection of atoms and generates a collection of annotation points.
The Pharmacophore Applications do not contain any hard-coded assumptions
about the nature of the annotation points; consequently, SVL programmers
can freely create custom annotation schemes.

There are several ways to customize or modify the annotation schemes:
</p>

<ol>
<li><b>Modify the Atom Typing Functions</b>.
All of the schemes rely, in one way or another, on specific SVL functions
that detect hydrogen bond donors/acceptors, cation/anions, hydrophobes, etc.
These functions are described in
<a href="../moe/fcnref/ph4_tlst.html">Pharmacophore Typing Functions</a>
and their source code is in <tt>$MOE/lib/svl/ph4.svl/ph4type.svl</tt>.
By modifying these functions all of the schemes can be globally customized
(say, to allow nitro oxygen as a hydrogen bond acceptor).
<b>Warning!</b> A change to the pharmacophore type functions will affect
all of the schemes and some molecular descriptors.
<b>Note!</b> Some schemes use private collections of rules for atom
typing.
</li>

<li><b>Modify an Existing Scheme</b>.
Some schemes have annotations that do not rely on the pharmacophore atom
typing functions.  For example, <b>Link</b> annotations are encoded directly
in the source code for the <tt>Unified</tt> scheme.  In these cases,
the scheme source code must be modified in order to customize the scheme.
The source code for the standard schemes is located in
<tt>$MOE/lib/svl/ph4.svl</tt> in files that start with <tt>ph4s_</tt>.
By modifying the scheme files directly, hydrophobe assignment or annotations
unique to the scheme can be customized.
<b>Warning!</b> A change to the standard schemes may result in non-standard
or unintended behavior.
</li>

<li><b>Develop a New Scheme</b>.
This is the most involved of the options.  A correctly implemented scheme
must provide a number of functions that will be used by the Pharmacophore
Applications.  These functions must conform to the conventions used by
the other Pharmacophore Applications.  It is good practice to start with
the source code for an existing scheme, such as <tt>Unified</tt> in
<tt>$MOE/lib/svl/ph4.svl/ph4s_unified.svl</tt>, change its name and then
change its code.  In this way, the standard behaviors can be preserved.
</li>

</ol>

<h2><a name="SeeAlso"></a>See Also</h2>

<a href="ph4_guide.htm">Introduction to Pharmacophores in MOE</a><br />
<a href="../moe/fcnref/ph4_tlst.html">Pharmacophore Typing Functions</a><br />
<a href="../mdb/wash.htm">Washing Molecules</a>, 
<a class="svl" href="../moe/fcnref/sdwash.htm#sdwash">sdwash</a><br />
<a href="ph4_query.htm">Pharmacophore Query Editor</a><br />
<a href="ph4_elu.htm">Pharmacophore Query Elucidator</a><br />
<a href="ph4_search.htm">Pharmacophore Search</a><br />
<a href="scaffold.htm">Scaffold Replacement</a><br />

<h2><a name="Ref"></a>References</h2>

<blockquote>
<table cellpadding="5" border="0">
<tr>
<td valign="top">[Lauri&nbsp;1994]</td>
<td valign="top">
Lauri, G., Bartlett, P.A.;
CAVEAT: A Program to Facilitate the Design of Organic Molecules;
<i>J. Comp. Aided Mol. Des. 8</i> (<b>1994</b>) 51&ndash;66.
</td>
</tr>
</table>
</blockquote>

<p><a href="../index.htm">MOE Table of Contents</a></p>
<hr noshade="noshade" />
<a href="http://www.chemcomp.com"><img src="../images/flogo.gif"
alt="CCG Logo"
align="left" width="30" height="30" border="1" hspace="5" vspace="3" /></a>
<font size="2">
<a href="../legal.html">Copyright</a> &copy; 1997-2010
<a href="http://www.chemcomp.com">Chemical Computing Group Inc.</a><br />
<a href="mailto:info@chemcomp.com"><i>info@chemcomp.com</i></a>
</font>
</body>
</html>
